Needle-free syringes administer a dose of fluid therapeutic agent or vaccine by ejecting a dose of the parental agent at the velocity exceeding the minimal level of safe and effective medicine delivery. Needle-free syringes have been well-known for more than fifty years. Conventionally, needle-free syringes consist of an enclosuer (container) which contains the dose of therapeutic agent, a piston movable inside the enclosure and an energy source that can drive a piston upon release, e.g., compressed gas or spring. When released, the stored energy accelerates the piston which expels the medicine at a speed sufficient for penetration into the patient's body. Existing needle-free syringes differ in the geometry, the shape and the size of the exit port and the design of the energy storage.
Needle-free syringes are currently being produced by a number of companies. They also have different patented designs. All patents can be split into three categories: 1—use a gas power for pressure of injection (for example, U.S. Pat. Nos. 6,210,359; 6,383,168B1; 6,645,170B2); 2—use a spring power for pressure of injection (for example, U.S. Pat. Nos. 5,722,953; 5,800,388; 6,123,684) and 3—use an electromechanical power and another mechanism for delivery of energy (for example, U.S. Pat. Nos. 6,939,323B2; 6,488,661B1).
Regardless of the syringe design, the amount of stored energy is reduced during the course of driving the piston and expulsion of the medicine. This reduction occurs regardless of the form of the storage and the exit port. As the pressure of the compressed gas drops or as the spring expands, there is a corresponding decrease in piston speed which results in the reduction of the rate of fluid exiting the syringe. In turn, this leads to a reduction of the speed and kinetic energy of the expelled medicine, and the speed of the trailing portion of the fluid ejected from the syringe is insufficient for penetration into the patient's body.
Thus, a part of the ejected fluid accumulates under the top layer of the skin, i.e., in the epidermis, which brings about unwanted consequences, including pain, redness and swelling at the site of injection. Variations, i.e., decrease, in the impact velocity of the medicine constitute a shortcoming of all existing needle-free syringes. It is an objective of this invention to prevent the reduction of the stream velocity of fluid medicines or vaccines expelled from a needle-free syringe, thereby prevent the accumulation of medicine under the skin.
The desired effect is attained by controlling the fluid pressure at the exit of the needle-free syringe. The minimal value of the exit pressure is attained by a pressure valve which closes the exit port when the fluid pressure drops below the critical level, e.g., after release of a volume of fluid from the syringe. Another control technique involves the use of two sources of energy injected sequentially into the fluid so that the second source is activated when the available energy of the first source drops below the critical level.
This present invention utilizes two approaches for prevention of the deterioration of the fluid stream and thus assuring complete penetration of the ejected fluid. The minimal critical speed of the ejected fluid is assured by a pressure valve or functionally similar structure (hereinafter “flow regulator”) installed at the exit port of the syringe such that the valve is opened, i.e., fluid is expelled, only if the fluid pressure proximate to the pressure port exceeds the critical level. So the valve in this case also functions as a nozzle. If this pressure drops below the critical value, the flow regulator closes, and the fluid flow is interrupted. The flow regulator may be, e.g., an elastic (rubber) washer or formed of two sheets of plastic contacting each other at a closed angle at respective edges thereof.
The syringe body can also be used as a control valve. In this case the part of the syringe which forms an exit port is elastic and allows the port to be opened only at the fluid pressure exceeding the critical value. Another mode of maintaining the desired level of the velocity of the exiting fluid is the use of two or more sources of energy. When the amount of energy in a storage currently used for driving a piston drops, another source of energy is activated, and the energy rate of the supply to the fluid exceeds the critical level.
Container 1 may be filled with fluid, and then stopper 2, which frictionally contacts the inner wall of container 1, may be inserted to contain the fluid. Thus, the end of stopper 2 that exerts pressure on the fluid 4 may be pointed, e.g., conical, or flat depending on the volume of fluid to be injected and whether or not it is necessary to pierce.
Fluid is released when the stoper's motion deforms or expands washer 3 which is subjected to pressure equal to the pressure of the fluid inside container 1. When the expansion of washer 3 reaches the critical level, a puncture orifice is formed in washer 3 and opens, and the fluid dose begins exiting the container. The velocity of the exiting fluid is determined by the pressure developed by the fluid provided the pressure exceeds the critical level to force the washer open so that the fluid can escape. The require minimal fluid velocity is primarily determined by the elasticity of the material and the thickness of the washer 3. This feature assures additional stability of the washer position in the course of the fluid exit.
In
Compressed gas is provided in chamber 11 to further provide force on the piston 3 to eject the fluid before there is a substantial drop in the energy being exerted on stopper 9 by piston 3. A retaining mechanism 4 having a lip is provided on the lateral portion of piston 2 to hold piston 3 in a position by contact with a receiving slot in the piston 3 so that the gas in chamber 11 remains compressed until the retaining mechanism is released once the piston reaches the piston shown in
In operation, the pressure exerted on stopper 9 as well as the pressure exerted by the piston 2 on the fluid located beneath the piston increases. The stopper 9 with seal 10 is moved downward toward exit end of container 7 by force, e.g., by a spring and compressed air, or other means.
The exit section of the device may simultaneously contain more than one exit port with regulators of pressure working as nozzles.
The exit section of the syringe that contacts the skin is made from soft elastic material for reducing the impact effect of the inertia the pistons.